No-fault compensation schemes for COVID-19 medical products

Lancet. 2021 May 8;397(10286):1707-1708. doi: 10.1016/S0140-6736(21)00784-4.

Authors

Yasuhiro Fujiwara¹, Yutaka Onda², Shuichiro Hayashi³

Affiliations

¹ Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan. Electronic address: fujiwara-ce@pmda.go.jp.
² Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan.
³ Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / prevention & control*
Compensation and Redress*
Emergency Medicine*
Insurance, Liability*
Liability, Legal
Malpractice